Pediatric requirements in Europe stymie help for hemophilia

Nature Medicine

Volumn 20, Issue 2, 2014, Pages 117-

  Peyvandi, Flora ^a,b   Rosendaal, Frits R ^c   O'Mahony, Brian ^d   Mannuccio Mannucci, Pier ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d European Haemophilia Consortium   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOLOGIC AGENT;

CHILD; CHILDHOOD DISEASE; DRUG CONTROL; EUROPE; HEMOPHILIA; HUMAN; NOTE; PRIORITY JOURNAL;

CHILD; CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; EUROPEAN UNION; GOVERNMENT REGULATION; HEMOPHILIA A; HUMANS; TIME FACTORS;

EID: 84893655316     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0214-117     Document Type: Note

References (3)

1. Powell, J.S. et al. N. Engl. J. Med. 369, 2313-2323 (2013).
2. Mahlangu, J. et al. Blood 123, 317-325 (2014).
3. Rosendaal, F.R. & Briët, E. Thromb. Haemost. 63,145 (1990).